Cancer genomics: Promises and complexities

Clinical Cancer Research

Volumn 7, Issue 8, 2001, Pages 2159-2167

  Zhang, W ^a   Laborde P M ^a   Coombes, K R ^a   Berry, D A ^a   Hamilton, S R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER RESEARCH; CHROMOSOME DELETION; GENE AMPLIFICATION; GENE EXPRESSION; MEDICAL GENETICS; PRIORITY JOURNAL; SHORT SURVEY; TECHNOLOGY;

DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMAN GENOME PROJECT; HUMANS; NEOPLASMS;

EID: 0034886709     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (125)

1. Deaths. Final data for 1998
2. The hallmarks of cancer
3. The critical role of chromosome translocation in human leukemia
4. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences
5. Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors
6. Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas
7. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
8. The role of DNA methylation in cancer genetics and epigenetics
9. Tumor heterogeneity: Morphological, molecular and clinical implications
10. The importance of heterogeneity in tumor pathology
11. The DNA sequence of human chromosome 22
12. The DNA sequence of human chromosome 21
13. "Working draft" of human genome available by June
14. The human genome project
15. Shotgun sequencing of the human genome
16. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays
17. Expression-based genetic/physical maps of single-nucleotide polymorphisms identified by the cancer genome anatomy project
18. dbSNP. A database of single nucleotide polymorphisms
19. Bacillus anthracis, a bug with attitude!
20. The genome sequence of Rickettsia prowazekii and the origin of mitochondria
21. Overview of the yeast genome
22. The C. elegans sequencing consortium. Genome sequence of the nematode C. elegans: A platform for investigating biology
23. The genome sequence of Drosophila melanogaster
24. The future of clinical research: The role of genomics, informatics, and evidence based medicine
25. Functional genomics: From disease-oriented to personalized medicine
26. Environmental health and genomics: Visions and implications
27. Hunting for disease genes in multi-functional diseases
28. The limits of clinical genomics
29. Genomic medicine and the future of health care
30. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
31. Cancer and genomics
32. Our genome unveiled
33. Use of cDNA microarrays to analyze gene expression patterns in human cancer
34. Genomics, gene expression and DNA arrays
35. Options available-from start to finish-for obtaining expression data by microarray
36. Mining the human genome using microarrays of open reading frames
37. Serial analysis of gene expression
38. Analyzing uncharted transcriptomes with SAGE
39. Comparative genomic hybridization for cytogenetic analysis of solid tumors
40. High resolution analysis of cDNA copy number variation using comparative genomic hybridization to microarrays
41. Hybridization analyses of arrayed cDNA libraries
42. High density synthetic oligonucleotide arrays
43. Analysis of human transcriptomes
44. Minisage: Gene expression profiling using serial analysis of gene expression from 1 μg total RNA
45. Generation of longer cDNA fragments from serial analysis of gene expression tags for gene identification
46. Molecular cytogenetic analysis of breast cancer cell lines
47. Comparison of comparative genomic hybridization and interphase fluorescence in situ hybridization in ovarian carcinomas: Possibilities and limitations of both techniques
48. Cytogenetic characterization of two colon cell lines by using conventional G-banding, comparative genomic hybridization, and whole chromosome painting
49. The age of cancer
50. Genomics in the public domain: Strategy and policy
51. The post-genome era: Medical promise with problems
52. Honing genomics tools
53. Structural genomics: From cottage industry to industrial revolution
54. Intellectual property. Publication rights in the era of open data release
55. Automation technology applications in a genomics center
56. st century
57. Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells
58. Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase
59. Growth factor binding protein 2 expression in glioblastoma multiforme: A revelation by parallel gene expression profiling
60. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques
61. Genomic analysis of metastasis reveals an essential role for RhoC
62. Serial analysis of gene expression identifies putative metastasis-associated transcripts in colon tumor cell lines
63. Identifying markers for pancreatic cancer by gene expression analysis
64. Genes expressed in human tumor endothelium
65. Pharmacogenomics: Translating functional genomics into rational therapeutics
66. Discovering novel chemotherapeutic drugs for the third millennium
67. Idiosyncratic reactions to drags: Can medicine response profiles provide a dynamic drug surveillance system?
68. Characterization of cellular pathways involved in glioblastoma response to chemotherapeutic agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling
69. Retinoic acid-induced apoptotic pathway in T-cell lymphoma. Identification of four groups of genes with differential biological functions
70. Differential gene expression between normal and tumor-derived ovarian epithelial cells
71. Comparative genomic hybridization study of de novo myeloid neoplasia
72. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas
73. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma
74. Comparative genomics hybridization detects novel amplifications in fibroadenomas of the breast
75. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding
76. Localization of tumor suppressor activity important in non-small cell lung carcinoma on chromosome 11q
77. PIKCA is implicated as an oncogene in ovarian cancer
78. Genome-wide analysis of DNA copy number changes using cDNA microarrays
79. New tools in molecular pathology-commentary
80. Molecular profiling of human cancer
81. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
82. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
83. Molecular classification of cutaneous malignant melanoma by gene expression profiling
84. Molecular mechanisms underlying human synovial sarcoma development
85. Gene expression profiles in hereditary breast cancer
86. Gene expression profiles in thyroid carcinomas
87. Systematic variation in gene expression patterns in human cancer cell lines
88. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas
89. Molecular portraits of human breast tumours
90. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia
91. Use of arsenic trioxide (As203) in the treatment of acute promyelocytic leukemia (APL). I. As203 exerts dose-dependent dual effects on APL cells
92. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas
93. erbB-2, p53 and efficacy of adjuvant therapy in lymph node-positive breast cancer
94. d2 cluster: A validated method for clustering EST and full-length cDNA sequences
95. Large-scale clustering of cDNA-fingerprinting data
96. An algorithm for clustering cDNA fingerprints
97. Tissue microarrays: What will they bring to molecular and anatomic pathology?
98. Tissue microarrays for high-throughput molecular profiling of tumor specimens
99. High-throughput SNP genotyping by allele-specific PCR with universal energy transfer-labeled primers
100. Semiautomated clone verification by real-time PCR using molecular beacons
101. Laser capture microdissection
102. The use of laser capture microdissection to obtain distinct populations of cells for proteomic analysis
103. Antisense RNA amplification. A linear amplification method for analyzing the mRNA population from single living cells
104. High-fidelity mRNA amplification for gene profiling
105. Bioinformatics tools for whole genomes
106. Visualization of data
107. Information processing issues and solutions associated with microarray technology
108. The origins of bioinformatics
109. Ratio-based decisions and the quantitative analysis of cDNA microarray images
110. Data management and analysis for gene expression arrays
111. Genomics: Beyond the book of life
112. Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology
113. Microarray technology-enhanced versatility, persistent challenge
114. Finding function through structural genomics
115. Fishing expeditions
116. Guilt by association
117. Cancer. Enhanced: Proximity matters
118. How much use is the human genome project?
119. Genomics: Journey to the center of biology
120. Scientific commentary: The scientific foundations and medical and social prospects of the human genome project
121. Genetics, biology and disease
122. Applications of display technology in protein analysis
123. Protein biochips for differential profiling